Claudia Maletzki
Claudia Maletzki is an expert in Oncology at University of Rostock (Germany). Claudia Maletzki has authored 130 publications, the most recent in 2026. SLR score: 484 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Biochemistry - Hematology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 130
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Perivascular spaces are associated with T cell trafficking and may have prognostic relevance in brain metastases. PMID 42897263 — cells, brain, neoplasms, phenotype, neoplasm metastasis, basal ganglia, t-lymphocytes, ganglia | Commun Med (Lond) | 2026 | 0 |
| CDK2/9 blockade remodels chromatin and drives phenotypic plasticity in glioblastoma organoids. PMID 42829432 — microglia, cells, up-regulation, genes, astrocytes, temozolomide, cell survival, brain, neoplasms, chromatin, organoids, glioblastoma, therapeutics | Cell Commun Signal | 2026 | 0 |
| Cumulative pre-chemoimmunotherapy dexamethasone dose is associated with adverse outcomes in primary central nervous system lymphoma. PMID 42824035 — microscopy, electron, scanning transmission, dexamethasone, lymphoma, central nervous system, therapeutics, nervous system | Front Oncol | 2026 | 0 |
| Machine learning-guided multimodal profiling defines perturbed immune states at the time of cancer diagnosis. PMID 42308424 — cells, blood, neoplasms, multiple chronic conditions, machine learning, diagnosis, therapeutics, learning | Brief Bioinform | 2026 | 0 |
| Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancer. PMID 42294482 — cytokines, cells, genes, neoplasms, biomarkers, immunotherapy, squamous cell carcinoma of head and neck, organoids, immunity, head and neck neoplasms, therapeutics | Immunooncol Technol | 2026 | 1 |
LeadR Networks
Main global connection map